FDA Approved: DOCETAXEL — Supplemental Application (Sanofi-Aventis U.S. LLC)

View source ↗

Summary

FDA approved a supplemental application for docetaxel, resulting in changes to the product labeling. The changes may include updates to indications, dosing, and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastric Cancer
• Head and Neck Cancer
• Non-small Cell Lung Cancer
• Prostate Cancer

Drugs mentioned

• Taxotere (docetaxel)

Snippet

SUPPL AP for DOCETAXEL (DOCETAXEL)